Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?

Langenbeck's Archives of Surgery

Volumn 397, Issue 6, 2012, Pages 917-925

  Janot, M S ^a   Kersting, S ^a   Belyaev, O ^a   Matuschek, A ^a   Chromik, A M ^a   Suelberg, D ^a   Uhl, W ^a   Tannapfel, A ^b   Bergmann, U ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Curative operation; International Union Against Cancer; Outcome; Pancreatic ductal adenocarcinoma; R classification; Royal College of Pathologists

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL UNION AGAINST CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROYAL COLLEGE OF PATHOLOGISTS;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84865123282     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0953-5     Document Type: Article

References (36)

1. M Carpelan-Holmstrom S Nordling E Pukkala R Sankila J Luttges G Kloppel C Haglund 2005 Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry Gut 54 385 387 15710987 10.1136/gut.2004.047191 1:STN:280:DC%2BD2M%2FotFGqtQ%3D%3D (Pubitemid 40299095)
2. C Sperti C Pasquali A Piccoli S Pedrazzoli 1997 Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 195 200 8995078 10.1007/s002689900215 1:STN:280:DyaK2s7lt1ensA%3D%3D (Pubitemid 27053441)
3. N Alexakis C Halloran M Raraty P Ghaneh R Sutton JP Neoptolemos 2004 Current standards of surgery for pancreatic cancer Br J Surg 91 1410 1427 15499648 10.1002/bjs.4794 1:STN:280:DC%2BD2crksVyjtQ%3D%3D (Pubitemid 39518076)
4. I Esposito J Kleeff F Bergmann C Reiser E Herpel H Friess P Schirmacher MW Buchler 2008 Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 1651 1660 18351300 10.1245/s10434-008-9839-8
5. KV Menon D Gomez AM Smith A Anthoney CS Verbeke 2009 Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP) HPB (Oxford) 11 18 24 10.1111/j.1477-2574.2008.00013. x
6. CS Verbeke 2008 Resection margins and R1 rates in pancreatic cancer-are we there yet? Histopathology 52 787 796 18081813 10.1111/j.1365-2559.2007.02935. x 1:STN:280:DC%2BD1czjtVKnuw%3D%3D (Pubitemid 351724902)
7. G Butturini DD Stocken MN Wente H Jeekel JH Klinkenbijl KE Bakkevold T Takada H Amano C Dervenis C Bassi MW Buchler JP Neoptolemos 2008 Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg 143 75 83 18209156 10.1001/archsurg.2007.17 discussion 83 (Pubitemid 351159303)
8. CS Verbeke D Leitch KV Menon MJ McMahon PJ Guillou A Anthoney 2006 Redefining the R1 resection in pancreatic cancer Br J Surg 93 1232 1237 16804874 10.1002/bjs.5397 1:STN:280:DC%2BD28rntlKnsA%3D%3D (Pubitemid 44547022)
9. Sobin LH, Gospodarowicz MK, Wittekind C (2009) International Union Against Cancer TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Oxford
10. The Royal College of Pathologists (2002) Standards and minimum datasets for reporting cancers. Minimum datasets for the histopathological reporting of pancreatic, ampulla of Vater and bile duct carcinoma. The Royal College of Pathologists, London
11. ID Nagtegaal CA Marijnen EK Kranenbarg CJ van de Velde JH van Krieken 2002 Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit Am J Surg Pathol 26 350 357 11859207 10.1097/00000478-200203000-00009 (Pubitemid 34184459)
12. A Wibe PR Rendedal E Svensson J Norstein TJ Eide HE Myrvold O Soreide 2002 Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer Br J Surg 89 327 334 11872058 10.1046/j.0007-1323.2001.02024.x 1:STN:280:DC%2BD387jslequg%3D%3D (Pubitemid 34227032)
13. DK Chang AL Johns ND Merrett AJ Gill EK Colvin CJ Scarlett NQ Nguyen RW Leong PH Cosman MI Kelly RL Sutherland SM Henshall JG Kench AV Biankin 2009 Margin clearance and outcome in resected pancreatic cancer J Clin Oncol 27 2855 2862 19398572 10.1200/JCO.2008.20.5104
14. Compton CC (2005) College of American Pathologists. Leeds Protocol. http://www.Cap.Org/apps/docs/cancer-protocols/2005/pancreasexo05-pw.Doc
15. A Tannapfel 2010 [Pancreatic cancer. Molecular and surgical pathology] Pathologe 31 Suppl 2 225 228 1:STN:280:DC%2BC3czhtVSjsg%3D%3D
16. Kloppel G, Hruban RH, Longnecker DS (2000) Ductal adenocarcinoma of the pancreas. In: Hamilton SR, Aaltonen LA (eds) WHO classification of tumours: pathology and genetics of tumours of the digestive system. IARC, Lyon, pp 221-230
17. S Pedrazzoli V DiCarlo R Dionigi F Mosca P Pederzoli C Pasquali G Kloppel K Dhaene F Michelassi 1998 Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group Ann Surg. 228 508 517 9790340 10.1097/00000658- 199810000-00007 1:STN:280:DyaK1M%2FgsFSjsg%3D%3D (Pubitemid 30194394)
18. M Kayahara T Nagakawa K Ueno T Ohta T Takeda I Miyazaki 1993 An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 2118 2123 8104092 10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2- 4 1:STN:280:DyaK3szos1Kgug%3D%3D (Pubitemid 23280135)
19. H Kurahara S Takao K Maemura H Shinchi S Natsugoe T Aikou 2007 Impact of lymph node micrometastasis in patients with pancreatic head cancer World J Surg 31 483 490 17219277 10.1007/s00268-006-0463-0 discussion 91-2 (Pubitemid 46356085)
20. J Albores-Saavedra C Heffess RH Hruban D Klimstra D Longnecker 1999 Recommendations for the reporting of pancreatic specimens containing malignant tumors. The Association of Directors of Anatomic and Surgical Pathology Am J Clin Pathol 111 304 307 10078104 1:STN:280:DyaK1M7nslygsg%3D%3D (Pubitemid 29102737)
21. J Kleeff C Reiser U Hinz J Bachmann J Debus D Jaeger H Friess MW Buchler 2007 Surgery for recurrent pancreatic ductal adenocarcinoma Ann Surg 245 566 572 17414605 10.1097/01.sla.0000245845.06772.7d (Pubitemid 46555660)
22. F Campbell RA Smith P Whelan R Sutton M Raraty JP Neoptolemos P Ghaneh 2009 Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin Histopathology 55 277 283 19723142 10.1111/j.1365-2559.2009.03376.x
23. A Westgaard S Tafjord IN Farstad M Cvancarova TJ Eide O Mathisen OP Clausen IP Gladhaug 2008 Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor BMC Cancer 8 5 18194510 10.1186/1471-2407-8-5 (Pubitemid 351298389)
24. M Wagner C Redaelli M Lietz CA Seiler H Friess MW Buchler 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 586 594 15122610 10.1002/bjs.4484 1:STN:280:DC%2BD2c3it1ansA%3D%3D (Pubitemid 38624667)
25. TJ Howard JE Krug J Yu NJ Zyromski CM Schmidt LE Jacobson JA Madura EA Wiebke KD Lillemoe 2006 A margin-negative r0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer J Gastrointest Surg 10 1338 1345 17175452 10.1016/j.gassur.2006.09.008 discussion 45-6 (Pubitemid 44909002)
26. NP Jarufe C Coldham AD Mayer DF Mirza JA Buckels SR Bramhall 2004 Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region Dig Surg 21 202 209 15218236 10.1159/000079346 1:STN:280:DC%2BD2czntVKguw%3D%3D (Pubitemid 39070131)
27. JM Winter JL Cameron KA Campbell MA Arnold DC Chang J Coleman MB Hodgin PK Sauter RH Hruban TS Riall RD Schulick MA Choti KD Lillemoe CJ Yeo 2006 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg 10 1199 1210 17114007 10.1016/j.gassur.2006.08.018 discussion 210-1 (Pubitemid 44781200)
28. CP Raut JF Tseng CC Sun H Wang RA Wolff CH Crane R Hwang JN Vauthey EK Abdalla JE Lee PW Pisters DB Evans 2007 Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 52 60 17592291 10.1097/01.sla.0000259391.84304.2b (Pubitemid 47012207)
29. J Hernandez J Mullinax W Clark P Toomey D Villadolid C Morton S Ross A Rosemurgy 2009 Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins Ann Surg 250 76 80 19561479 10.1097/SLA.0b013e3181ad655e
30. MV Perini AL Montagnini J Jukemura S Penteado EE Abdo R Patzina I Cecconello JE Cunha 2008 Clinical and pathologic prognostic factors for curative resection for pancreatic cancer HPB (Oxford). 10 356 362 10.1080/ 13651820802140752 1:STN:280:DC%2BD1cjhsFSqsA%3D%3D
31. MF Brennan MW Kattan D Klimstra K Conlon 2004 Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas Ann Surg 240 293 298 15273554 10.1097/01.sla.0000133125.85489.07 (Pubitemid 38963021)
32. JL Cameron DW Crist JV Sitzmann RH Hruban JK Boitnott AJ Seidler J Coleman 1991 Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer Am J Surg 161 120 124 1987845 10.1016/0002-9610(91)90371-J 1:STN:280:DyaK3M7gtlekuw%3D%3D discussion 24-5
33. KF Kuhlmann SM de Castro JG Wesseling FJ ten Kate GJ Offerhaus OR Busch TM van Gulik H Obertop DJ Gouma 2004 Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients Eur J Cancer 40 549 558 14962722 10.1016/j.ejca.2003.10.026 1:STN:280: DC%2BD2c%2FntlKgsw%3D%3D (Pubitemid 38220772)
34. W Meyer C Jurowich M Reichel B Steinhauser PH Wunsch C Gebhardt 2000 Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas Surg Today 30 582 587 10930222 10.1007/s005950070096 1:STN:280:DC%2BD3M%2FlvVChuw%3D%3D (Pubitemid 30489833)
35. A Nakao S Takeda M Sakai T Kaneko S Inoue H Sugimoto N Kanazumi 2004 Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection Pancreas 28 289 292 15084973 10.1097/00006676-200404000-00014 (Pubitemid 38437325)
36. W Hartwig T Hackert U Hinz A Gluth F Bergmann O Strobel MW Buchler J Werner 2011 Pancreatic cancer surgery in the new millennium: better prediction of outcome Ann Surg 254 311 319 21606835 10.1097/SLA.0b013e31821fd334